brainjo has raised €2m for VR mental health tech, with its first product focused on children with ADHD.
The Regensburg-based startup develops Digital Health Applications, known as DiGAs, which can be prescribed by therapists or physicians and reimbursed by health insurance.
Its VR-based tools are designed to complement traditional psychotherapy rather than replace it, allowing patients to use them at home.
Markus Wensauer, co-founder and chief executive of brainjo, said: “With a strong network of business angels, MEDICE – The Health Family as a strategic partner, and HTGF as a leading European seed investor, we are ideally positioned to bring our solutions into healthcare and establish multimodal therapy offerings for patients.”
The company said limited therapy availability, long waiting lists and insufficient access to mental health services continue to challenge healthcare systems.
It aims to address those gaps by using virtual reality as a prescribable extension to psychotherapy, designed to improve accessibility and patient adherence.
The funding will support a clinical study and the regulatory approval of brainjo’s first VR-based DiGA.
This initial product, focused on children with ADHD, is being developed in collaboration with MEDICE – The Health Family. Market approval is planned for 2028.
The seed round was led by High-Tech Gründerfonds, with additional participation from strategic partners and business angels, including Andreas Weinhut and better ventures.
